Compare
5 stocks, side by sideRelative performance · rebased to 100
INDVKNSAAMRXRGCLQDA
| INDVIndivior Pharmaceuticals, Inc. | KNSAKiniksa Pharmaceuticals International, plc | AMRXAmneal Pharmaceuticals, Inc. | RGCRegencell Bioscience Holdings Limited | LQDALiquidia Corporation | |
|---|---|---|---|---|---|
| Smart Score | 7/10 | 8/10 | 7/10 | - | 8/10 |
| Price | $41.29 | $56.89 | $17.32 | $7.49 | $76.92 |
| 1 month | +9.2% | +7.6% | +35% | -69% | +28% |
| 1 year | +197% | +96% | +113% | -67% | +458% |
| 5 year | +265% | +285% | +212% | - | +2770% |
| P/E (TTM) | 19.4 | 36.1 | 45.2 | - | 306.7 |
| P/E vs sector | -38% | +14% | +44% | - | +873% |
| Market cap | $4.9B | $4.4B | $5.5B | $3.7B | $6.8B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.